HB966 - Relating To Access To Treatment For Terminally Ill Patients.
Hawaii - 2024 Regular Session
Introduced byDella au Belatti, Terez Amato, Ernesto M. Ganaden
Last updated over 1 year ago
16 Co-Sponsors
Beginning on 1/1/2024, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions. Effective 7/1/3000. (HD1)
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now